JPRN-UMIN000020683已完成2 期
A Phase II/III Study of NPC-09 (N-acetylneuraminic acid) in Patients with GNE Myopathy (GNEM) - A Phase II/III Study of NPC-09 (N-acetylneuraminic acid) in Patients with GNE Myopathy (GNEM)
Tohoku University Hospital, Department of Neurology0 个研究点目标入组 20 人开始时间: 2016年1月25日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 50years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •-Ingestion of N-acetyl-D-mannosamine (ManNAc), SA, or related metabolites; intravenous immunoglobulin (IVIG); or anything that can be metabolized to produce SA in the body within 60 days prior to the Screening Visit -History of more than 30 days treatment with SA-ER and/or SA-IR in prior clinical trials in the past year -Has had any hypersensitivity to SA or its excipients that, in the judgment of the investigator, places the subject at increased risk for adverse effects -Has serum transaminase (i.e. aspartate aminotransferase [AST] or gamma-glutamyl transpeptidase [GGT]) levels greater than 3X the upper limit of normal (ULN) for age/gender, or serum creatinine of greater than 2X ULN at Screening -Pregnant or breastfeeding at Screening or planning to become pregnant (self or partner) at any time during the study -Use of any investigational product or investigational medical device within 30 days prior to Screening, or anticipated requirement for any investigational agent prior to completion of all scheduled study assessments -Has a condition of such severity and acuity, in the opinion of the investigator, that it warrants immediate surgical intervention or other treatment or may not allow safe participation in the study -Has a concurrent disease, active suicidal ideation, or other condition that, in the view of the investigator, places the subject at high risk of poor treatment compliance or of not completing the study, or would interfere with study participation or would affect safety -More than 400 mL blood donation within 16 weeks -Presence of alcohol or drug dependency -Patients whom the investigator judges not to be appropriate for the subject
研究者
相似试验
进行中（未招募）
3 期
Efficacy confirmation study of NPC-09Distal myopathy with rimmed vacuoles (DMRV), hereditary inclusion body myopathy (hIBM)JPRN-jRCT2021200030Suzuki Ryoichi10
招募中
3 期
Evaluation of The Effect of N-acetylcysteine in The Prevention of Vancomycin-Induced Renal Disorder.IRCT20150721023282N6Esfahan University of Medical Sciences60
招募中
2 期
Effect of N-acetylcysteine in the improvement of AphthousRecurrent aphthous stomatitis.Recurrent oral aphthaeIRCT20180728040614N1Sari University of Medical Sciences46
招募中
2 期
ecitumumab and Gemcitabine combination therapy for advanced Biliary tract cancer with EGFR Amplification phase2 TrialJPRN-jRCTs031230259Sugimori Makoto18
招募中
4 期
A clinical trial to study the effect of N-acetyl cysteine in patients with Chronic Obstructive Pulmonary Disease.CTRI/2011/11/002138Cipla Ltd30